Status:
COMPLETED
Caffeine, Resistance Exercise and EMG
Lead Sponsor:
University of Alcala
Conditions:
Caffeine
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Introduction: Several studies have evaluated and confirmed the ergogenic effects of acute caffeine intake on sports performance. However, some studies suggest that this effect predominantly occurs in ...
Eligibility Criteria
Inclusion
- Age between 18 and 35 years.
- Body Mass Index (BMI) \< 25 kg/m².
- Resistance-trained individuals (more than 2 years of structured training).
- Healthy men and women without neurological, cardiometabolic, immunological, or physical conditions that prevent them from exercising.
- Participants must be able to perform the tests described in the following section.
Exclusion
- History of neuromuscular diseases, heart disease, or conditions that may affect liver or muscle metabolism.
- Use of drugs, stimulants, or sports supplements that could interfere with the dietary supplement used in the study.
- Sedentary habits (less than 150 minutes/week of moderate exercise).
- Having undergone prolonged periods of physical inactivity in the 6 months prior to the study.
- Engaging in strenuous exercise within 48 hours prior to the tests.
- Failure to replicate the same food intake on both experimental days.
- Consumption of caffeine or any other stimulant after 6 pm on the day before the tests, to avoid headaches, discomfort, or lethargy in regular caffeine consumers.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06606652
Start Date
September 1 2023
End Date
April 30 2024
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá
Alcalá de Henares, Madrid, Spain, 28805